Scott M Steward-Tharp

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi New insights into T cell biology and T cell-directed therapy for autoimmunity, inflammation, and immunosuppression
    Scott M Steward-Tharp
    Molecular Immunology and Inflammation Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA
    Ann N Y Acad Sci 1183:123-48. 2010
  2. ncbi Modulation of innate and adaptive immune responses by tofacitinib (CP-690,550)
    Kamran Ghoreschi
    Molecular Immunology and Inflammation Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD 20892, USA
    J Immunol 186:4234-43. 2011

Detail Information

Publications2

  1. ncbi New insights into T cell biology and T cell-directed therapy for autoimmunity, inflammation, and immunosuppression
    Scott M Steward-Tharp
    Molecular Immunology and Inflammation Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA
    Ann N Y Acad Sci 1183:123-48. 2010
    ..Within this context, we examine existing T cell-directed therapies, including new agents being evaluated in clinical and preclinical studies. We also use recent findings to speculate on novel targets...
  2. ncbi Modulation of innate and adaptive immune responses by tofacitinib (CP-690,550)
    Kamran Ghoreschi
    Molecular Immunology and Inflammation Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD 20892, USA
    J Immunol 186:4234-43. 2011
    ..Thus, CP-690,550 may improve autoimmune diseases and prevent transplant rejection by suppressing the differentiation of pathogenic Th1 and Th17 cells as well as innate immune cell signaling...